We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Oil States International
OIS
$489M
| $276K | ﹤0.01% |
+4,320
| New | +$254K |
|
|
SLXP
827
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $276K | ﹤0.01% |
2,234
-99,345
| -98% | -$11M |
|
828
PUT
Advanced Energy
AEIS
$11.6B
| $275K | ﹤0.01% |
+14,300
| New | +$292K |
|
|
MRIN
829
DELISTED
Marin Software
MRIN
| $273K | ﹤0.01% |
+554
| New | +$236K |
|
830
PUT
Saia
SAIA
$9.27B
| $273K | ﹤0.01% |
+6,200
| New | +$257K |
|
831
TFS Financial
TFSL
$5.16B
| $273K | ﹤0.01% |
+19,141
| New | +$257K |
|
832
PUT
Nike
NKE
$61.9B
| $272K | ﹤0.01% |
+7,000
| New | +$260K |
|
|
CBR
833
DELISTED
CIBER Inc.
CBR
| $271K | ﹤0.01% |
54,823
-27,018
| -33% | -$122K |
|
834
Corpay
CPAY
$25B
| $270K | ﹤0.01% |
+2,047
| New | +$250K |
|
|
FARM
835
DELISTED
Farmer Brothers
FARM
| $269K | ﹤0.01% |
12,417
-3,743
| -23% | -$75.1K |
|
836
PUT
Alto Ingredients
ALTO
$369M
| $268K | ﹤0.01% |
+17,500
| New | +$242K |
|
837
PUT
Palo Alto Networks
PANW
$270B
| $268K | ﹤0.01% |
+19,200
| New | +$224K |
|
|
LLL
838
PUT
DELISTED
L3 Technologies, Inc.
LLL
| $266K | ﹤0.01% |
2,200
-2,400
| -52% | -$285K |
|
|
AGU
839
DELISTED
Agrium
AGU
| $266K | ﹤0.01% |
2,900
-8,600
| -75% | -$798K |
|
|
MJN
840
DELISTED
Mead Johnson Nutrition Company
MJN
| $264K | ﹤0.01% |
+2,838
| New | +$248K |
|
|
KW
841
DELISTED
Kennedy-Wilson Holdings
KW
| $262K | ﹤0.01% |
9,760
-13,388
| -58% | -$319K |
|
|
ENOC
842
CALL
DELISTED
EnerNOC, Inc.
ENOC
| $261K | ﹤0.01% |
13,800
-23,500
| -63% | -$474K |
|
843
CALL
GameStop
GME
$9.75B
| $259K | ﹤0.01% |
25,600
-42,400
| -62% | -$415K |
|
844
Jefferies Financial Group
JEF
$12.6B
| $259K | ﹤0.01% |
+11,014
| New | +$256K |
|
845
PUT
3M
MMM
$90.9B
| $258K | ﹤0.01% |
2,153
-7,176
| -77% | -$842K |
|
|
DATA
846
CALL
DELISTED
Tableau Software, Inc.
DATA
| $256K | ﹤0.01% |
+3,600
| New | +$226K |
|
|
RTI
847
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $251K | ﹤0.01% |
+9,472
| New | +$254K |
|
848
PUT
Caterpillar
CAT
$375B
| $250K | ﹤0.01% |
+2,300
| New | +$241K |
|
|
849
CALL
Alto Ingredients
ALTO
$369M
| $249K | ﹤0.01% |
+16,300
| New | +$226K |
|
850
Teradata
TDC
$2.92B
| $248K | ﹤0.01% |
+6,154
| New | +$269K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.